Toxicity in C57BL/6 mouse xenografted with mouse LLC cells assessed as body weight loss at 30 mg/kg/day, sc administered on day 9 to day 12 of tumor implantation
Toxicity in C57BL/6 mouse xenografted with mouse LLC cells assessed as body weight loss at 15 mg/kg/day, sc administered on day 9 to day 13 of tumor implantation
Toxicity in C57BL/6 mouse xenografted with mouse LLC cells assessed as body weight loss at 30 mg/kg/day, ip administered on day 9 to day 12 of tumor implantation
Antineoplastic activity against mouse LLC cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 25 mg/kg/day, ip administered on day 10 to day 14 of tumor implantation measured on day 12
Antineoplastic activity against mouse LLC cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 25 mg/kg/day, ip administered on day 10 to day 14 of tumor implantation measured on day 14
Antineoplastic activity against mouse LLC cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 25 mg/kg/day, ip administered on day 10 to day 14 of tumor implantation measured on day 17
Antineoplastic activity against mouse LLC cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 25 mg/kg/day, ip administered on day 10 to day 14 of tumor implantation measured on day 19
Antineoplastic activity against mouse LLC cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 25 mg/kg/day, ip administered on day 10 to day 14 of tumor implantation measured on day 21
Antineoplastic activity against mouse LLC cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 25 mg/kg/day, ip administered on day 10 to day 14 of tumor implantation measured on day 24
Antineoplastic activity against mouse LLC cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 50 mg/kg/day, ip administered on day 10 to day 14 of tumor implantation measured on day 12
Antineoplastic activity against mouse LLC cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 50 mg/kg/day, ip administered on day 10 to day 14 of tumor implantation measured on day 14
Antineoplastic activity against mouse LLC cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 50 mg/kg/day, ip administered on day 10 to day 14 of tumor implantation measured on day 17
Antineoplastic activity against mouse LLC cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 50 mg/kg/day, ip administered on day 10 to day 14 of tumor implantation measured on day 19
Antineoplastic activity against mouse LLC cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 50 mg/kg/day, ip administered on day 10 to day 14 of tumor implantation measured on day 21
Antineoplastic activity against mouse LLC cells xenografted in C57BL/6 mouse assessed as tumor growth inhibition at 50 mg/kg/day, ip administered on day 10 to day 14 of tumor implantation measured on day 24